Precision BioSciences Revenue and Competitors

Location

$175.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Precision BioSciences's estimated annual revenue is currently $118M per year.(i)
  • Precision BioSciences received $40.0M in venture funding in March 2019.
  • Precision BioSciences's estimated revenue per employee is $786,933
  • Precision BioSciences's total funding is $175.2M.
  • Precision BioSciences's current valuation is $361M. (January 2022)

Employee Data

  • Precision BioSciences has 150 Employees.(i)
  • Precision BioSciences grew their employee count by -39% last year.

Precision BioSciences's People

NameTitleEmail/Phone
1
Chief People Officer, Precision BioSciencesReveal Email/Phone
2
SVP Chemistry, Manufacturing, and Controls (CMC)Reveal Email/Phone
3
VP, Operations and Information TechnologyReveal Email/Phone
4
Head Supply & Operations PlanningReveal Email/Phone
5
General CounselReveal Email/Phone
6
VP, Intellectual PropertyReveal Email/Phone
7
VP, Research OperationsReveal Email/Phone
8
SVP Human ResourcesReveal Email/Phone
9
VP, GenomcsReveal Email/Phone
10
VP, Gene Therapy DiscoveryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Precision BioSciences?

Precision BioSciences is a privately held biotechnology company dedicated to improving lives through its next generation gene editing technology, ARCUS. Precision's cell therapy, gene therapy, and agriculture programs are based on the proprietary ARC endonuclease, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow not to mention plentifully stocked kitchens and benefits like wellness massage. At Precision BioSciences, we are excited to work together toward improving lives by realizing the potential of gene editing.

keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power

$175.2M

Total Funding

150

Number of Employees

$118M

Revenue (est)

-39%

Employee Growth %

$361M

Valuation

N/A

Accelerator

Precision BioSciences News

2022-04-17 - Is Precision BioSciences Inc (DTIL) a Bad Choice in Biotechnology Friday?

Precision BioSciences Inc gets a 72 rank in the Biotechnology industry. Biotechnology is number 74 out of 148 industries. Overall Score - 51.

2022-04-13 - Precision BioSciences, Inc. (NASDAQ:DTIL) Given Average ...

Precision BioSciences, Inc, a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the...

2022-04-13 - Analyst Rating: Will Precision BioSciences Inc (DTIL) Stock Beat the Market?

That average rating earns Precision BioSciences Inc an Analyst Ranking of 59, which means it ranks higher than 59 of stocks, based on data...

2019-09-08 - Precision BioSciences to Present at Upcoming Scientific Conferences

DURHAM, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (DTIL) (“Precision”), a genome editing company dedicated ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1516%N/A
#2
$21.7M152-3%N/A
#3
$50.2M1529%N/A
#4
$26.9M153-1%N/A
#5
$31M15456%N/A

Precision BioSciences Funding

DateAmountRoundLead InvestorsReference
2015-05-12$25.6MAvenBioArticle
2018-06-11$88.1MUndisclosedArticle
2018-06-27$110.0MUndisclosedArrowMark PartnersArticle
2019-03-12$40.0MUndisclosedMulitpleArticle